Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Silent cerebral embolism during percutaneous valve implantation does not appear to cause cognitive impairment

Original title: Cognitive trajectory after transcatheter aortic valve implantation. Reference: Ghanem A et al. Circulation Cardiovasc Intervent. 2013;Epub ahead of print

 

Several studies showed that silent cerebral embolism in patients undergoing percutaneous aortic valve replacement is frequent but seems that does not affect the long-term cognitive functions according to this new study. 

This study included 111 patients who received a percutaneous valve and an assessment of their cognitive functions pre-procedure and subsequently at 3 days, 3 months, 1 year and 2 years.

All patients had normal results pre-procedure and except for one case of ischemic stroke at 8 months post implant no other neurological events were observed in the rest of the population. The overall population mortality at 2 years was 31.5 %. Cognitive decline was observed early (in the evaluation at 3 days) in 6 patients (5.4 %) of which in 3 patients, deterioration persisted at follow-up. The few who experienced cognitive decline were mainly affected by their construction and visual skills as well as language, attention and memory. 105 patients (94.6 %) which showed no early deterioration evolved stable in most of the tests performed on the track. Hemodialysis patients were more predisposed to early deterioration (50 % versus 5%, P = 0.009) as well as those who required longer procedures (123 min versus 85 min , P = .03 ). Bleeding complications were not associated with further deterioration. Of the total, 56 patients underwent MRI showing signs of stroke in 64%. When comparing patients with and without evidence of stroke on MRI, there were no differences in cognitive function at 2 years follow up. The only predictor of cognitive decline at follow up (as expected) was age.

Conclusion: 

Long-term cognitive performance remained stable in most patients receiving percutaneous valve despite the high intrinsic risk of this population. 

Editorial Comment

Cognitive function consists of multiple parts (ie. Language, memory, etc.), each must be evaluated for a specific test, making it quite cumbersome to find subtle differences. Patients usually get tired after performing the first tests which might decrease their performance at least; in fact the attention is one of the functions to be evaluated. This study, conducted at a single center and with relatively few patients, does not seem to close the case with regard to the association between stroke and cognition.

SOLACI.ORG

More articles by this author

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...